Citoxlab, a CRO for non-clinical research, invested in and partnered with Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), a well-recognized CRO providing comprehensive services for preclinical oncology research worldwide.   Founded in 1997, EPO is an AAALAC accredited organization. It provides in vitro and in vivo testing of drug candidates with antitumoral and/or immunostimulatory activities in the…

Citoxlab Group, a non-clinical CROs, has entered into a definitive agreement to acquire Solvo Biotechnology, a CRO specializing in drug transporter studies and the assessment of Drug-Drug Interactions (DDI).    Founded in 1999, Solvo Biotechnology is an international CRO in the field of drug transporter research. This field is growing rapidly as the investigation of…